Markets Review: RSA adds 59% in November global vaccine-led rally

Share’s in London-listed RSA gained almost 60 percent in November as UK and European stocks closed their best month in more than three decades, after a rally powered by Covid-19 vaccine breakthroughs.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Andy Stone

Sales manager

+44 (0) 77 4160 9204

andy.stone@thomsonreuters.com

    Ricky Lamey

    Business development executive

    ricky.lamey@thomsonreuters.com

      Share price